Cargando…
Nanoparticle-Based Treatment in Glioblastoma
Glioblastoma (GB) is a malignant glioma associated with a mean overall survival of 12 to 18 months, even with optimal treatment, due to its high relapse rate and treatment resistance. The standardized first-line treatment consists of surgery, which allows for diagnosis and cytoreduction, followed by...
Autores principales: | Roque, Diogo, Cruz, Nuno, Ferreira, Hugo Alexandre, Reis, Catarina Pinto, Matela, Nuno, Herculano-Carvalho, Manuel, Cascão, Rita, Faria, Claudia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532799/ https://www.ncbi.nlm.nih.gov/pubmed/37763096 http://dx.doi.org/10.3390/jpm13091328 |
Ejemplares similares
-
Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma
por: Cruz, Nuno, et al.
Publicado: (2023) -
Cerebellar cystic glioblastomas: An uncommon presentation of a rare disease and clinical review
por: Lavrador, José Pedro, et al.
Publicado: (2018) -
A Novel Hybrid Nanosystem Integrating Cytotoxic and Magnetic Properties as a Tool to Potentiate Melanoma Therapy
por: Cruz, Nuno, et al.
Publicado: (2020) -
An update of advanced nanoplatforms for Glioblastoma Multiforme Management
por: Amaral, Mariana, et al.
Publicado: (2021) -
Make It Less Complex: Autoencoder for Speckle Noise Removal—Application to Breast and Lung Ultrasound
por: Oliveira-Saraiva, Duarte, et al.
Publicado: (2023)